Who is sponsoring NCT04779684?

NCT04779684 is sponsored by Ralf J. Jox.

What condition does NCT04779684 study?

NCT04779684 studies Advanced Dementia, Loss of Medical Decision Making Capacity.

Is NCT04779684 still recruiting?

NCT04779684 is currently completed. Last updated 1 December 2023.

Last reviewed 2023-12-01 · How we verify

NCT04779684: PROSPECT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Promoting Self-determination for Institutionalized Older People Without Decision-making Capacity: Advance Care Planning by Proxy

Completed NA Last updated 1 December 2023

What this trial tests

NA trial testing Advance care planning by proxy for health care proxies of people without medical decision making capacity in Advanced Dementia in 20 participants. Completed in 31 October 2023.

Timeline

1 August 2021

Primary endpoint
30 October 2023

31 October 2023

Quick facts

Lead sponsor	Ralf J. Jox
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	20
Start date	1 August 2021
Primary completion	30 October 2023
Estimated completion	31 October 2023
Sites	1 location across Switzerland

Drugs / interventions tested

Advance care planning by proxy for health care proxies of people without medical decision making capacity

Conditions studied

Advanced Dementia — all drugs for Advanced Dementia →
Loss of Medical Decision Making Capacity — all drugs for Loss of Medical Decision Making Capacity →

Sponsor

Ralf J. Jox

Who can join

Adults 70 to 110, any sex, with Advanced Dementia or Loss of Medical Decision Making Capacity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to test the acceptability and feasibility of an advance care planning (ACP) intervention which has been developed to be used with the health care proxies of residential aged care facility (RACF) residents who no longer have decision making capacity for medical decisions. The intervention involves two discussions that are facilitated by a trained health professional. The first discussion aims to discuss the resident's life story, values, previous medical treatments and experiences with illness and death and whether or not they have previously documented their wishes for future care. The second discussion also involves the treating physician and aims to document anticipatory decisions for emergency situations. Follow-up discussions after 12 months or any change in situation will be conducted.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Advance care planning by proxy for residential aged care facility residents: results of a pilot interventional study.
Jones L, Rubli Truchard E, Sterie AC, Rhyner Y, et al · · 2026 · PMID 42131731 · DOI 10.1093/geroni/igag033

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04779684 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ralf J. Jox
Last refreshed: 1 December 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04779684.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing